TCV Trust & Wealth Management’s Merck MRK Stock Holding History

TCV Trust & Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.05M	Sell	54,884 -1,479	-3%	-$173K	0.53%	47
2026 Q1	$6.78M	Sell	56,363 -1,820	-3%	-$210K	0.57%	47
2025 Q4	$6.12M	Sell	58,183 -193	-0.3%	-$18.1K	0.49%	53
2025 Q3	$4.9M	Buy	58,376 +364	+0.6%	+$30K	0.41%	59
2025 Q2	$4.59M	Sell	58,012 -100	-0.2%	-$7.95K	0.4%	60
2025 Q1	$5.22M	Sell	58,112 -1,866	-3%	-$174K	0.48%	54
2024 Q4	$5.97M	Sell	59,978 -351	-0.6%	-$36.2K	0.55%	50
2024 Q3	$6.85M	Sell	60,329 -559	-0.9%	-$66.4K	0.61%	50
2024 Q2	$7.54M	Sell	60,888 -1,150	-2%	-$148K	0.72%	47
2024 Q1	$8.19M	Sell	62,038 -4,912	-7%	-$605K	0.78%	47
2023 Q4	$7.3M	Sell	66,950 -530	-0.8%	-$55K	0.74%	47
2023 Q3	$6.95M	Buy	67,480 +838	+1%	+$90.3K	0.77%	46
2023 Q2	$7.69M	Sell	66,642 -3,546	-5%	-$403K	0.82%	42
2023 Q1	$7.47M	Buy	70,188 +786	+1%	+$84.9K	0.83%	45
2022 Q4	$7.7M	Sell	69,402 -1,117	-2%	-$114K	0.87%	42
2022 Q3	$6.07M	Sell	70,519 -2,616	-4%	-$234K	0.77%	48
2022 Q2	$6.67M	Buy	73,135 +304	+0.4%	+$26.9K	0.8%	48
2022 Q1	$5.98M	Sell	72,831 -305	-0.4%	-$24K	0.64%	54
2021 Q4	$5.61M	Sell	73,136 -411	-0.6%	-$32.7K	0.56%	57
2021 Q3	$5.52M	Buy	73,547 +272	+0.4%	+$20.7K	0.61%	55
2021 Q2	$5.66M	Sell	73,275 -3,947	-5%	-$294K	0.62%	56
2021 Q1	$5.68M	Sell	77,222 -4,352	-5%	-$321K	0.66%	54
2020 Q4	$6.37M	Sell	81,574 -15,637	-16%	-$1.2M	0.77%	48
2020 Q3	$7.69M	Sell	97,211 -959	-1%	-$75.1K	1.04%	38
2020 Q2	$7.24M	Sell	98,170 -5,727	-6%	-$431K	1.03%	40
2020 Q1	$7.63M	Sell	103,897 -3,153	-3%	-$248K	1.25%	32
2019 Q4	$9.29M	Sell	107,050 -5,006	-4%	-$411K	1.13%	34
2019 Q3	$9M	Sell	112,056 -1,651	-1%	-$132K	1.16%	35
2019 Q2	$9.1M	Buy	113,707 +1,104	+1%	+$84.5K	1.18%	33
2019 Q1	$8.94M	Sell	112,603 -770	-0.7%	-$57.6K	1.18%	33
2018 Q4	$8.27M	Buy	113,373 +56,517	+99%	+$3.99M	1.21%	33
2018 Q3	$3.85M	Buy	56,856 +1,798	+3%	+$115K	0.51%	54
2018 Q2	$3.19M	Buy	55,058 +2,523	+5%	+$142K	0.45%	60
2018 Q1	$2.73M	Buy	52,535 +775	+1%	+$41.9K	0.39%	65
2017 Q4	$2.78M	Sell	51,760 -462	-0.9%	-$25.6K	0.39%	66
2017 Q3	$3.19M	Sell	52,222 -1,174	-2%	-$71.2K	0.47%	58
2017 Q2	$3.27M	Sell	53,396 -749	-1%	-$45.6K	0.49%	59
2017 Q1	$3.28M	Sell	54,145 -718	-1%	-$43.6K	0.5%	57
2016 Q4	$3.08M	Sell	54,863 -2,044	-4%	-$120K	0.5%	57
2016 Q3	$3.39M	Sell	56,907 -4,061	-7%	-$237K	0.57%	55
2016 Q2	$3.35M	Sell	60,968 -2,626	-4%	-$140K	0.58%	55
2016 Q1	$3.21M	Sell	63,594 -655	-1%	-$32.1K	0.58%	59
2015 Q4	$3.24M	Buy	64,249 +2,249	+4%	+$113K	0.57%	57
2015 Q3	$2.92M	Sell	62,000 -52	-0.1%	-$2.76K	0.53%	58
2015 Q2	$3.37M	Sell	62,052 -738	-1%	-$41.4K	0.55%	55
2015 Q1	$3.44M	Sell	62,790 -2,148	-3%	-$122K	0.56%	56
2014 Q4	$3.52M	Sell	64,938 -96	-0.1%	-$5.35K	0.58%	58
2014 Q3	$3.68M	Sell	65,034 -328	-0.5%	-$18.4K	0.62%	56
2014 Q2	$3.61M	Buy	65,362 +1,492	+2%	+$81.4K	0.59%	58
2014 Q1	$3.46M	Sell	63,870 -935	-1%	-$48.4K	0.58%	58
2013 Q4	$3.1M	Buy	64,805 +2,610	+4%	+$119K	0.53%	63
2013 Q3	$2.83M	Sell	62,195 -1,934	-3%	-$88.3K	0.55%	62
2013 Q2	$2.84M	Buy	+64,129	New	+$2.86M	0.58%	57

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

TCV Trust & Wealth Management's MRK Position: Q2 2026 in Review

TCV Trust & Wealth Management reduced its Merck (MRK) stake by 2.6% in Q2 2026, selling an estimated $173K and leaving 54,884 shares worth $7.05M. The position accounts for 0.53% of the portfolio, ranked #47.

TCV Trust & Wealth Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.29M in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

TCV Trust & Wealth Management held 54,884 shares of Merck worth $7.05M as of Q2 2026.
TCV Trust & Wealth Management sold 1,479 Merck shares in Q2 2026, an estimated $173K.
Merck made up 0.53% of TCV Trust & Wealth Management's portfolio in Q2 2026, its #47 holding.
TCV Trust & Wealth Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
TCV Trust & Wealth Management's Merck position peaked at $9.29M in Q4 2019.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.